| DCDGX | WCMLX | DCDGX / WCMLX | |
| Total Expense Ratio | 2.25 | 0.99 | 227% |
| Annual Report Gross Expense Ratio | 2.25 | 1.79 | 126% |
| Fund Existence | 22 years | 7 years | - |
| Gain YTD | 19.420 | 11.410 | 170% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000 | 100000 | 5% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 83.2M | 51.9M | 160% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 24.54 | 17.02 | 144% |
| Returns for 3 years | 52.63 | 32.50 | 162% |
| Returns for 5 years | -13.73 | 3.16 | -434% |
| Returns for 10 years | 10.14 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JGRJX | 38.01 | 0.17 | +0.45% |
| JPMorgan Growth Advantage R2 | |||
| FCUDX | 21.00 | 0.08 | +0.38% |
| NYLI PineStone U.S. Equity Class R6 | |||
| TSPIX | 5.74 | 0.02 | +0.35% |
| Transamerica Small Cap Growth I2 | |||
| HFDYX | 22.83 | 0.07 | +0.31% |
| Hartford Schroders US MidCap Opps Y | |||
| FSMEX | 53.57 | N/A | N/A |
| Fidelity Select Medical Tech and Devcs | |||